InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Publication of Study Demonstrating Benefits of Proprietary Data-Driven Approach to Digital Health
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has published a study in the peer-reviewed “Frontiers in Endocrinology” journal. According to the announcement, the study provides an overview of new research that confirms the benefit of Dario's integrated, data-driven approach to health and chronic-condition management. The study examined retrospective data from 989 users who regularly tracked their steps levels and blood glucose…